Literature DB >> 19037627

Metabolic consequences of a 50% partial pancreatectomy in humans.

B A Menge1, H Schrader, T G K Breuer, Y Dabrowski, W Uhl, W E Schmidt, J J Meier.   

Abstract

AIMS/HYPOTHESIS: Partial pancreatectomy is frequently performed in patients with pancreatic tumours or chronic pancreatitis, but little is known about the metabolic impact of this intervention. We examined the effects of approximately 50% partial pancreatectomy on glucose homeostasis and insulin secretion.
METHODS: Fourteen patients with chronic pancreatitis, ten patients with pancreatic carcinoma and 13 patients with benign pancreatic tumours or extra-pancreatic masses (control group) underwent 240 min oral glucose tolerance tests before and after pancreatic tail-resection (n = 12), duodenopancreatectomy (n = 19) or duodenum-preserving pancreatic-head resection (n = 6).
RESULTS: Partial pancreatectomy led to a reduction in post-challenge insulin excursions by 49% in chronic pancreatitis patients, 52% in carcinoma patients and 55% in controls (p < 0.05). Nevertheless, post-challenge glucose concentrations were transiently ameliorated after surgery (p < 0.001). In the control participants, pancreatic-head resection caused a transient reduction of post-challenge glycaemia, whereas pancreatic-tail resection increased both fasting and post-challenge glycaemia (p < 0.05). Insulin sensitivity was highest in chronic pancreatitis patients before surgery (p < 0.01), but remained unchanged by the partial pancreatectomy. High pre-operative body weight and elevated fasting glucose levels were associated with poor glycaemic control after surgery. CONCLUSIONS/
INTERPRETATION: Insulin secretion is diminished after pancreatic-head and -tail resection, but post-challenge glucose concentrations can be ameliorated after pancreatic-head resection. These data highlight the unequal impact of different surgical procedures on glucose control and suggest that obesity and high pre-operative glucose levels should be considered as risk factors for the development of hyperglycaemia after pancreatic surgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037627     DOI: 10.1007/s00125-008-1219-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

Review 1.  Beta cell mass in diabetes: a realistic therapeutic target?

Authors:  J J Meier
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

2.  Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis.

Authors:  Juris J Meier; Lise L Kjems; Johannes D Veldhuis; Pierre Lefèbvre; Peter C Butler
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

3.  Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig.

Authors:  L L Kjems; B M Kirby; E M Welsh; J D Veldhuis; M Straume; S S McIntyre; D Yang; P Lefèbvre; P C Butler
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

4.  Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis.

Authors:  R E Jimenez; C Fernandez-del Castillo; D W Rattner; Y Chang; A L Warshaw
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

5.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans.

Authors:  D M Kendall; D E Sutherland; J S Najarian; F C Goetz; R P Robertson
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

6.  Regulation of pancreatic beta-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse.

Authors:  Mina Peshavaria; Brooke L Larmie; James Lausier; Basanthi Satish; Aida Habibovic; Violet Roskens; Kyla Larock; Brian Everill; Jack L Leahy; Thomas L Jetton
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.

Authors:  S Larsen; J Hilsted; B Tronier; H Worning
Journal:  Metabolism       Date:  1987-10       Impact factor: 8.694

9.  Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.

Authors:  Juris J Meier; Baptist Gallwitz; Stefan Salmen; Oliver Goetze; Jens J Holst; Wolfgang E Schmidt; Michael A Nauck
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 10.  Inhibition of gastric emptying.

Authors:  Andrew Young
Journal:  Adv Pharmacol       Date:  2005
View more
  21 in total

Review 1.  The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.

Authors:  S E Kahn; S Zraika; K M Utzschneider; R L Hull
Journal:  Diabetologia       Date:  2009-03-27       Impact factor: 10.122

Review 2.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

Review 3.  Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes.

Authors:  Gordon C Weir; Jason Gaglia; Susan Bonner-Weir
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-29       Impact factor: 32.069

4.  Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy.

Authors:  Sachiyo Shirakawa; Ippei Matsumoto; Hirochika Toyama; Makoto Shinzeki; Tetsuo Ajiki; Takumi Fukumoto; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2012-09-28       Impact factor: 3.452

5.  Determinants of glucose control in patients with chronic pancreatitis.

Authors:  H Schrader; B A Menge; C Zeidler; P R Ritter; A Tannapfel; W Uhl; W E Schmidt; J J Meier
Journal:  Diabetologia       Date:  2010-03-09       Impact factor: 10.122

6.  Symptomatic change and gastrointestinal quality of life after pancreatectomy.

Authors:  Lewis Rashid; Vic Velanovich
Journal:  HPB (Oxford)       Date:  2011-10-25       Impact factor: 3.647

7.  Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes.

Authors:  Teresa Mezza; Pietro Manuel Ferraro; Gianfranco Di Giuseppe; Simona Moffa; Chiara Ma Cefalo; Francesca Cinti; Flavia Impronta; Umberto Capece; Giuseppe Quero; Alfredo Pontecorvi; Andrea Mari; Sergio Alfieri; Andrea Giaccari
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

8.  Autoimmune pancreatitis-related diabetes: quantitative analysis of endocrine islet cells and inflammatory infiltrate.

Authors:  Alton B Farris; Gregory Y Lauwers; Vikram Deshpande
Journal:  Virchows Arch       Date:  2010-07-15       Impact factor: 4.064

9.  Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetes.

Authors:  Yoshifumi Saisho; Erica Manesso; Alexandra E Butler; Ryan Galasso; Kylie Kavanagh; Mickey Flynn; Li Zhang; Paige Clark; Tatyana Gurlo; Gianna M Toffolo; Claudio Cobelli; Janice D Wagner; Peter C Butler
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

10.  Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors.

Authors:  Michael J Ferrara; Christine Lohse; Yogish C Kudva; Michael B Farnell; Florencia G Que; Kaye M Reid-Lombardo; John H Donohue; David M Nagorney; Suresh T Chari; Santhi S Vege; Michael L Kendrick
Journal:  HPB (Oxford)       Date:  2012-09-10       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.